Certain diabetes medications have recently been reported to be linked to thyroid cancer.
Onglyza (saxagliptin) belongs to the drug family called incretin mimetics, a class of drugs used to treat type-2 diabetes.
Kombiglyze XR, a combination drug, is also a part of this medication class, as it contains the same active ingredient as Onglyza, saxagliptin, along with metformin.
Onglyza reduces blood sugar by stopping the liver from producing too much glucose, and reducing the amount of glucagon from the pancreas. This drug accomplishes blood sugar regulation by encouraging the body to produce more insulin after meals, giving the body an overall balance of healthy blood sugar and insulin.
A highly popular choice in type-2 diabetes medications, Onglyza is praised for its ability to help control blood sugar while not causing weight gain. In 2012, Onglyza had sales of $709 million dollars, with analysts predicting that it will increase to $2.47 billion by 2018.
Onglyza Side Effects
Onglyza has been linked with a number of serious conditions believed to be serious side effects from use of the drug. Two of these conditions include pancreatic cancer and heart failure, with the FDA releasing an official warning for heart failure in April 2015.
The risk of thyroid cancer is speculated to also be a Onglyza side effect due to numerous adverse event reports to the FDA, and researchers are continuing to study the association.
Onglyza was released in 2009 and incretin mimetics have only been on the market since 2006, resulting in little information available regarding long-term side effects like thyroid cancer.
In the same year that Onglyza was released, the FDA asked Amylin Pharmaceuticals to investigate the potential link of thyroid cancer and another incretin mimetic Byetta.
While this study is still ongoing, Gastroenterology had published a study in 2011 that had observed thyroid cancer occurrences being reported to the FDA by patients taking diabetes drugs Byetta and Januvia. The possible association between treatment medications for diabetes and thyroid cancer has been a prevalent concern for several years and continues to be investigated.
It is important to note that this deadly cancer takes many years to develop, and is difficult to diagnose in early stages. Patients who are taking Onglyza are encouraged to be vigilant for any signs of thyroid cancer, for the malignant lumps can be removed if diagnosed early enough and offer a more favorable prognosis.
Early symptoms of thyroid cancer include: swelling on the neck, change in voice, hoarseness, unexplained coughing, trouble breathing and enlarged lymph nodes in the neck.
Onglyza Lawsuit Information
Individuals who have filed pharmaceutical drug lawsuits following a variety of side effects claim that they were not adequately warned against the drug’s complications and would not have used the drug otherwise. Such Onglyza lawsuits filed often seek compensation for medical bills, and other possible damages.
Patients who developed adverse Onglyza side effects are encouraged to take advantage a free case review to determine their options for seeking legal action.
In general, Onglyza lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Onglyza lawsuit or Ongylyza class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Onglyza Lawsuit Investigation
If you or a loved one were injured from Onglyza side effects such as heart failure, thyroid cancer or pancreatic cancer, you may have a legal claim. See if you qualify to pursue compensation and join a free Onglyza lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which diabetes drug did you/your loved one take?*
- Onglyza
- Kombiglyze XR
- Other (please describe in additional details box below)
- What year did you/your loved one start taking this medication?*
- Which of the following problems did you/your loved one experience after taking this medication?*
-
Heart Failure
-
Heart Attack
-
Pancreatic Cancer
-
Thyroid Cancer
-
Death
-
Other (please describe in the additional details box below)
-
- What year were you/your loved one diagnosed with one or more of these problems?*
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 141) {gformInitChosenFields(‘#input_141_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_141_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_141_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [141, 1]) } );
The post Diabetes Drug Onglyza Linked to Thyroid Cancer appeared first on Top Class Actions.
from http://topclassactions.com/lawsuit-settlements/lawsuit-news/295027-onglyza-thyroid-cancer-examined/
No comments:
Post a Comment